A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood

NCT05738291 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1839100
DRUG: Placebo matching BI 1839100
DRUG: midazolam
DRUG: digoxin
DRUG: rosuvastatin

Sponsor

Boehringer Ingelheim